LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449,660 | -43.4% | 7,504 | -31.9% | 0.05% | -41.3% |
| Q2 2023 | $794,999 | -20.0% | 11,026 | -18.4% | 0.09% | -23.3% |
| Q1 2023 | $994,188 | +8.9% | 13,515 | -1.1% | 0.12% | +2.6% |
| Q4 2022 | $913,178 | -31.3% | 13,670 | -11.5% | 0.12% | -37.4% |
| Q3 2022 | $1,330,000 | -3.5% | 15,445 | 0.0% | 0.19% | +5.6% |
| Q2 2022 | $1,378,000 | -20.7% | 15,445 | 0.0% | 0.18% | -9.2% |
| Q1 2022 | $1,737,000 | -20.4% | 15,445 | +9.4% | 0.20% | -15.9% |
| Q4 2021 | $2,181,000 | +6.0% | 14,120 | -4.4% | 0.23% | -2.1% |
| Q3 2021 | $2,057,000 | +6.2% | 14,763 | 0.0% | 0.24% | +7.7% |
| Q2 2021 | $1,937,000 | -13.9% | 14,763 | 0.0% | 0.22% | -19.1% |
| Q1 2021 | $2,251,000 | -7.9% | 14,763 | -39.9% | 0.27% | -13.4% |
| Q4 2020 | $2,444,000 | +172.5% | 24,575 | +161.0% | 0.31% | +143.4% |
| Q3 2020 | $897,000 | -13.9% | 9,415 | +1.1% | 0.13% | -27.5% |
| Q2 2020 | $1,042,000 | +40.1% | 9,314 | -9.0% | 0.18% | +14.8% |
| Q1 2020 | $744,000 | -34.4% | 10,230 | -6.0% | 0.16% | -3.1% |
| Q4 2019 | $1,135,000 | +4.2% | 10,879 | -0.6% | 0.16% | -5.3% |
| Q3 2019 | $1,089,000 | -13.8% | 10,940 | -1.1% | 0.17% | -14.6% |
| Q2 2019 | $1,263,000 | -48.0% | 11,062 | -42.7% | 0.20% | -50.6% |
| Q1 2019 | $2,427,000 | -72.0% | 19,303 | -69.8% | 0.40% | -74.0% |
| Q4 2018 | $8,668,000 | -50.0% | 63,873 | +1.1% | 1.54% | -41.4% |
| Q3 2018 | $17,347,000 | +19.7% | 63,196 | -9.7% | 2.64% | +7.1% |
| Q2 2018 | $14,497,000 | +16.5% | 69,976 | -7.1% | 2.46% | +20.2% |
| Q1 2018 | $12,444,000 | +19.4% | 75,344 | -1.0% | 2.05% | +15.8% |
| Q4 2017 | $10,420,000 | +7.2% | 76,094 | +6.6% | 1.77% | +4.0% |
| Q3 2017 | $9,723,000 | +18.4% | 71,413 | +5.5% | 1.70% | +8.8% |
| Q2 2017 | $8,215,000 | +16.7% | 67,669 | +1.7% | 1.56% | +13.5% |
| Q1 2017 | $7,041,000 | +17.6% | 66,523 | +12.9% | 1.38% | +7.7% |
| Q4 2016 | $5,986,000 | +8.1% | 58,908 | +8.6% | 1.28% | +6.9% |
| Q3 2016 | $5,535,000 | -19.8% | 54,228 | -6.3% | 1.20% | -20.5% |
| Q2 2016 | $6,900,000 | +4.7% | 57,852 | -6.0% | 1.50% | +3.5% |
| Q1 2016 | $6,588,000 | -2.9% | 61,517 | -1.6% | 1.45% | -5.2% |
| Q4 2015 | $6,782,000 | +25.5% | 62,549 | -0.9% | 1.53% | +13.8% |
| Q3 2015 | $5,405,000 | -9.4% | 63,104 | +6.8% | 1.35% | -2.0% |
| Q2 2015 | $5,964,000 | +196.3% | 59,104 | +126.4% | 1.37% | +162.2% |
| Q1 2015 | $2,013,000 | +45.9% | 26,110 | +0.7% | 0.52% | +43.6% |
| Q4 2014 | $1,380,000 | +37.3% | 25,930 | +21.2% | 0.36% | +30.8% |
| Q3 2014 | $1,005,000 | -16.1% | 21,395 | +11.3% | 0.28% | -13.6% |
| Q2 2014 | $1,198,000 | -15.2% | 19,225 | -8.5% | 0.32% | -20.2% |
| Q1 2014 | $1,413,000 | +20.2% | 21,000 | -6.1% | 0.40% | +17.4% |
| Q4 2013 | $1,176,000 | +21.5% | 22,360 | 0.0% | 0.34% | +16.9% |
| Q3 2013 | $968,000 | +1.0% | 22,360 | -12.7% | 0.30% | -6.1% |
| Q2 2013 | $958,000 | – | 25,615 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |